- Home
- SMSI vs PMN Comparison
SMSI vs PMN Comparison
Compare SMSI & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- PMN
- Stock Information
- Founded
- SMSI 1982
- PMN 2004
- Country
- SMSI United States
- PMN Canada
- Employees
- SMSI N/A
- PMN N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- PMN Pharmaceuticals and Biotechnology
- Sector
- SMSI Technology
- PMN Health Care
- Exchange
- SMSI Nasdaq
- PMN Nasdaq
- Market Cap
- SMSI 15.9M
- PMN 17.0M
- IPO Year
- SMSI 1995
- PMN N/A
- Fundamental
- Price
- SMSI $0.90
- PMN $0.49
- Analyst Decision
- SMSI Strong Buy
- PMN Strong Buy
- Analyst Count
- SMSI 1
- PMN 2
- Target Price
- SMSI $5.00
- PMN $4.50
- AVG Volume (30 Days)
- SMSI 103.7K
- PMN 42.3K
- Earning Date
- SMSI 07-31-2025
- PMN 08-07-2025
- Dividend Yield
- SMSI N/A
- PMN N/A
- EPS Growth
- SMSI N/A
- PMN N/A
- EPS
- SMSI N/A
- PMN N/A
- Revenue
- SMSI $19,378,000.00
- PMN N/A
- Revenue This Year
- SMSI $10.12
- PMN N/A
- Revenue Next Year
- SMSI $63.12
- PMN N/A
- P/E Ratio
- SMSI N/A
- PMN N/A
- Revenue Growth
- SMSI N/A
- PMN N/A
- 52 Week Low
- SMSI $0.52
- PMN $0.47
- 52 Week High
- SMSI $2.57
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- SMSI 55.29
- PMN 43.83
- Support Level
- SMSI $0.85
- PMN $0.48
- Resistance Level
- SMSI $0.98
- PMN $0.53
- Average True Range (ATR)
- SMSI 0.07
- PMN 0.03
- MACD
- SMSI 0.01
- PMN 0.00
- Stochastic Oscillator
- SMSI 69.75
- PMN 21.29
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.